Regarding 15L and 17L, we observed an increment in CDKN2A CN log ratio (from −4.2 to −0.4) along with the restoration of p16 expression (Fig. 6A), suggesting that selection of tumor cells retaining normal CDKN2A CN was favored upon treatment. This evidence concerns the gene CDKN2A and neoplasm.